curcumin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on serum alkaline phosphatase
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×3“There was no significant association between curcumin supplement and ALP [MD (95% CI) of −8.88 (−24.68, 6.93) units/L].”
Quoted verbatim from An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand.. - Study
- meta-analysis
- Dose
- 80–3000 mg/day pooled across bioavailability-enhanced forms (80–1000 mg/day), curcumin extracts (1500 mg/day) and turmeric powder (2000–3000 mg/day)
- Population
- Adults with MAFLD (NAFLD/NASH); 6 RCTs, all using bioavailability-enhanced curcumin forms; liver enzymes were a primary outcome of interest
Effect -8.88 mean difference, 95% CI -24.68 to 6.93
An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand.2023PMID:37037891Permalink
Keep reading
- Everything the graph holds on curcumin
- Every compound studied against Serum alkaline phosphatase
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M0GYKT5W8J22G7D4FHJZR73Q